新聞原文:
在這個 Regeneron v Kymab & Novo Nordisk判例中,英國上訴法院,採用EPO審查基準中通常知識者對於專利文件中的揭露水準,來判定Regeneron 所擁有的EP 1360287 與 EP 2264163專利中的第三個實施例未充分揭露,無法據以實施。
原文中對於歐洲專利局以及美國專利商標局對於「通常知識者」的定義中有基本的說明。兩者略有差異,要點在通常知識者是否具有創造力的差別,參考如下。
The “skilled person” under European law is a capable person with typical knowledge in the relevant field, but exercises no creativity. That skilled person will follow the instructions given in the disclosure and supplement that information only with information that is, without question, commonly known and immediately apparent to the skilled person.
Under U.S. patent law, the person of ordinary skill is a capable person with typical knowledge in the relevant field and the typical creativity for a person in that field.
These differences in the characteristics of the skilled person (or person of ordinary skill in the art) can lead to instances where a patent application that meets the enablement requirement under the law of one jurisdiction fails to meet the requirement in another jurisdiction.